Asheley Walker

Asheley Walker advises private and public companies of all stages on a variety of corporate matters including formation, financing activities, corporate governance and securities law compliance. Asheley also represents companies and underwriters in initial public offerings and follow-on securities offerings and counsels public companies with respect to SEC reporting obligations.

Asheley has recently worked on completed securities offerings by the following companies: ADC Therapeutics, Albireo Pharma, argenx, BigCommerce, Clearside Biomedical, Entasis Therapeutics, IMARA, Kezar Life Sciences, Meredith, NextCure, Ovid Therapeutics, Passage Bio, Precision Biosciences, Schrodinger, Taysha Gene Therapies, Tenable, Translate Bio and  X4 Pharma.

Asheley has also represented investment banks in capital markets transactions including: BofA Securities, Barclays, BMO, Canaccord Genuity, Cowen, Citigroup, Evercore, Goldman Sachs, Jefferies, J.P. Morgan, KeyBanc Capital Markets, Morgan Stanley, Needham, Piper Jaffray, Raymond James, SVB Leerink and Truist.